Aditya Kohli is Director at HilleVax, Inc. (HLVX). They have made 2 open-market trades across 1 company since 2024, most recently 2025-09-17.
CIK 0001791402
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HLVX | 698,171 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2025-06-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HLVX | SELL · 10b5-1 | 2024-05-20 | 2024-05-22 | $14.80 | $266K | -2.5% | -7.4% | -87.0% |
| HLVX | SELL · 10b5-1 | 2024-05-01 | 2024-05-03 | $14.03 | $97K | +10.8% | -9.0% | -87.0% |
| HLVX | SELL · 10b5-1 | 2024-04-03 | 2024-04-05 | $14.69 | $264K | -13.6% | -4.8% | -3.0% |
| HLVX | SELL | 2024-03-20 | 2024-03-20 | $16.42 | $99K | -2.3% | -23.2% | -20.1% |
| HLVX | SELL · 10b5-1 | 2024-03-18 | 2024-03-20 | $17.50 | $315K | -2.3% | -23.2% | -20.1% |
| HLVX | SELL · 10b5-1 | 2024-03-06 | 2024-03-08 | $18.66 | $336K | -12.2% | -21.9% | -25.0% |
| HLVX | SELL · 10b5-1 | 2024-02-20 | 2024-02-22 | $14.95 | $269K | +28.6% | +9.4% | -5.8% |
| HLVX | SELL · 10b5-1 | 2024-02-12 | 2024-02-14 | $15.32 | $92K | +15.6% | +19.5% | -12.8% |
| HLVX | SELL | 2024-02-08 | 2024-02-12 | $14.93 | $265K | +6.0% | +20.6% | -8.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.